The results exhibited that NLRP3 is involved in the inflammatory response during the development of NEC, so the effective inhibition of the activation of the NLRP3 inflammasome may provide insights for the development of new drugs for the therapy of NEC [14]. The gene discussed is NLRP3; the disease is necrotizing enterocolitis.